Recombinant Human TXN2 /Thioredoxin-2 Protein (rh TXN2 / Thioredoxin-2) Thr 60 - Gly 166 (Accession # AAH13726) was produced in E.coli cells at ACROBiosystems.
rh TXN2 / Thioredoxin-2 is fused with a polyhistidine tag at the N-terminus, and has a calculated MW of 12.8 kDa. The predicted N-terminus is Met. DTT-reduced Protein migrates as 13 kDa in SDS-PAGE .
Less than 1.0 EU per μg of the rh TXN2 / Thioredoxin-2 by the LAL method.
>97% as determined by SDS-PAGE.
Lyophilized from 0.22 μm filtered solution in 50 mM Tris, 150 mM NaCl,pH8.0. Normally Mannitol or Trehalose are added as protectants before lyophilization.
Contact us for customized product form or formulation.
See Certificate of Analysis for reconstitution instructions and specific concentrations.
Avoid repeated freeze-thaw cycles.
No activity loss was observed after storage at:
In lyophilized state for 1 year (4oC); After reconstitution under sterile conditions for 3 months (-70oC).
Thioredoxin-2 (TXN2),a member of the thioredoxin family,is also known as mitochondrial (MTRX or Mt-Trx) and TRX2.TXN2 have two important domains: Redox-active center and Transit peptide. TXN2 has an anti-apoptotic function and plays an important role in the regulation of mitochondrial membrane potential. Also, TXN2 could be involved in the resistance to anti-tumor agents. TNX2 possesses a dithiol-reducing activity as well.
Please contact us via TechSupport@acrobiosystems.com if you have any question on this product.